Trevena Inc. [NASDAQ: TRVN] traded at a high on 07/24/20, posting a 2.59 gain after which it closed the day’ session at $1.98. The company report on June 3, 2020 that Trevena Announces Advancement of Oliceridine Clinical Development in China by Jiangsu Nhwa Pharmaceutical Co..
Oliceridine is a new chemical entity intended for the management of moderate-to-severe acute pain.
Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the Company’s partner in China has been approved by the Chinese National Medical Products Administration (NMPA) to initiate clinical trials for IV oliceridine, Trevena’s lead investigational asset for the management of moderate-to-severe acute pain. Jiangsu Nhwa holds an exclusive license agreement for the development and commercialization of oliceridine in China.
The results of the trading session contributed to over 2100523 shares changing hands. Over the past one week, the price volatility of Trevena Inc. stands at 13.04% while the volatility over the past one month is 9.65%.
The market cap for TRVN stock reached $206.89 million, with 107.18 million shares outstanding and 105.79 million shares in the current float. Compared to the average trading volume of 3.21M shares, TRVN reached a trading volume of 2100523 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Trevena Inc. [TRVN]?
H.C. Wainwright have made an estimate for Trevena Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 31, 2019. The new note on the price target was released on November 05, 2018, representing the official price target for Trevena Inc. stock.
The Average True Range (ATR) for Trevena Inc. is set at 0.17, with the Price to Sales ratio for TRVN stock in the period of the last 12 months amounting to 6673.88. The Price to Book ratio for the last quarter was 6.60, with the Price to Cash per share for the same quarter was set at 0.27.
How has TRVN stock performed recently?
Trevena Inc. [TRVN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.61. With this latest performance, TRVN shares gained by 13.14% in over the last four-week period, additionally plugging by 103.37% over the last 6 months – not to mention a rise of 117.82% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TRVN stock in for the last two-week period is set at 65.90, with the RSI for the last a single of trading hit 67.91, and the three-weeks RSI is set at 66.77 for Trevena Inc. [TRVN]. The present Moving Average for the last 50 days of trading for this stock 1.5176, while it was recorded at 1.9840 for the last single week of trading, and 0.9567 for the last 200 days.
Trevena Inc. [TRVN]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Trevena Inc. [TRVN] shares currently have an operating margin of -85393.55. Trevena Inc.’s Net Margin is presently recorded at -80229.03.
Return on Total Capital for TRVN is now -51.67, given the latest momentum, and Return on Invested Capital for the company is -59.05. Return on Equity for this stock declined to -69.47, with Return on Assets sitting at -43.72. When it comes to the capital structure of this company, Trevena Inc. [TRVN] has a Total Debt to Total Equity ratio set at 44.75. Additionally, TRVN Total Debt to Total Capital is recorded at 30.92, with Total Debt to Total Assets ending up at 28.64. Long-Term Debt to Equity for the company is recorded at 25.95, with the Long-Term Debt to Total Capital now at 17.92.
Reflecting on the efficiency of the workforce at the company, Trevena Inc. [TRVN] managed to generate an average of -$1,036,292 per employee.Trevena Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 11.40 and a Current Ratio set at 11.40.
Earnings analysis for Trevena Inc. [TRVN]
With the latest financial reports released by the company, Trevena Inc. posted -0.05/share EPS, while the average EPS was predicted by analysts to be reported at -0.08/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 37.50%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TRVN.
Insider trade positions for Trevena Inc. [TRVN]
There are presently around $34 million, or 19.00% of TRVN stock, in the hands of institutional investors. The top three institutional holders of TRVN stocks are: VANGUARD GROUP INC with ownership of 3,915,315, which is approximately 0% of the company’s market cap and around 0.70% of the total institutional ownership; NEA MANAGEMENT COMPANY, LLC, holding 3,811,691 shares of the stock with an approximate value of $7.55 million in TRVN stocks shares; and BLACKROCK INC., currently with $5.2 million in TRVN stock with ownership of nearly -0.21% of the company’s market capitalization.
Positions in Trevena Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 21 institutional holders increased their position in Trevena Inc. [NASDAQ:TRVN] by around 625,116 shares. Additionally, 15 investors decreased positions by around 236,523 shares, while 24 investors held positions by with 16,432,266 shares. The mentioned changes placed institutional holdings at 17,293,905 shares, according to the latest SEC report filing. TRVN stock had 9 new institutional investments in for a total of 244,094 shares, while 8 institutional investors sold positions of 210,314 shares during the same period.